Izotropic Corporation (CSE: IZO)
Canada
· Delayed Price · Currency is CAD 0.0450
+0.0050 (12.50%)
Dec 19, 2024, 4:00 PM EST
Izotropic Company Description
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers.
It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses.
Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
Izotropic Corporation
| Country | Canada |
| Founded | 2016 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Robert Thast |
Contact Details
Address: 800-15355 24th Avenue Surrey, V4A 2H9 Canada | |
| Phone | 833-496-2677 |
| Website | izocorp.com |
Stock Details
| Ticker Symbol | IZO |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| ISIN Number | CA46604F1099 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Robert Louis Thast | Founder, Interim Chief Executive Officer and Chairman |
| Dr. Younes Achkire Ph.D. | Executive Vice President of Product Engineering and Chief Operating Officer |
| Ali Reza Sodagar | Legal Advisor and Independent Director |
| Jaclyn Thast | Operations Manager and Corporate Secretary |